Pharmafile Logo
Pharmafocus logo
Advanced Search

Michael Cohen

Showing 4 posts of 4 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News
michael_cohen_-_chip_somodevilla_-_getty_images

Trump ex-lawyer Cohen reveals Novartis pushed him to lobby

February 28, 2019
Sales and Marketing Donald Trump, Michael Cohen, Novartis, US, pharma

Among the swirling storm emanating from the testimony of Donald Trump’s ex-lawyer Michael Cohen to the House Oversight Committee, one …

News
novartis_side_building

Novartis’ top lawyer retires from role over botched Trump deal

May 16, 2018
Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …

News

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026